Article: Celecoxib in preventing skin cancer in patients with actinic keratoses.(Clinical Trial Review)

This study is currently recruiting patients.

Sponsored by UAB Comprehensive Cancer Center, National Cancer Institute (NCI)

Chemoprevention therapy is the use of certain drugs to try to prevent the development or recurrence of cancer. The use of celecoxib may be an effective way to prevent actinic keratoses. This is a randomized Phase II/III trial to determine the effectiveness of celecoxib in preventing skin cancer in patients who ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!